SL Investment Management (SL), one of the largest TEPs and life settlements investment providers in Europe, is to explore further expansion alternative assets to support clients in mitigating continued volatility.
After a run of natural and economic disasters during 2011, SL predicts that volatility mitigation will be the key challenge of asset managers during 2012, and predicts an ever-increasing appetite to explore asset classes that demonstrate lower levels of volatility than mainstream assets whilst continuing to offer attractive projected returns on investment.
The recent launch of early stage fund private equity fund Deepbridge Innovation Fund (DBIF), has garnered significant interest, because it partners SL’s asset management expertise with proven leaders in early stage funding in new technologies. This is exemplified through the recent appointment of the Fund’s investment committee chair, Sir Richard Sykes, widely acknowledged for his roles as Chairman of Council of The Royal Institution of Great Britain, Chairman of the UK Stem Cell Foundation and formerly as Chief Executive and Chairman of GlaxoWellcome and GlaxoSmithKline respectively.
SL, which began life as Surrenda-link and has over 20 years of solid experience in traded endowment policies, has demonstrated its ability to adapt and evolve before, when it moved into the life settlements space in 2002; SL is now one of the largest life settlements investment advisors outside the US. The company’s innovative approach, experience and flexible thinking, twinned with the stability and predictability of the secondary assets market means that SL is able to branch out into new alternative assets and claims it is the first secondary life investment provider to do so.
Patrick McAdams, Investment Director at SL, says: “Volatility mitigation will stay at the top of the agenda for the foreseeable future and SL is keen to develop opportunities which allow risk transparent access to alternative assets to help combat this. The link here is that SL will continue to operate within low-correlated markets. It is an important step for the future growth and development of SL and one which extends our core range from secondary life assets which are and will always be the strength at the heart of the business.
“SL strongly believes that any calculated risk should come from the asset itself and not from the stability of the investment provider or the investment structure itself. Values like caution and good governance may not set pulses racing but SL’s grounded approach has put the company in the unique and privileged position of being able to pursue opportunities that other providers with less clout and market longevity would be unable to explore.”